Navigation Links
S.L.E. Lupus Foundation announces new grants to further NYC scientists' leadership in lupus research
Date:4/5/2011

New York City's S.L.E. Lupus Foundation is pleased to name the latest recipients of its Career Development and Basic Science Fellowships: Josephine Isgro, MD of Hospital for Special Surgery (HSS), Dipyaman Ganguly, PhD of Columbia University Medical Center, and Yi Yan, PhD of the Feinstein Institute at North Shore-Long Island Jewish (LIJ) Hospital.

These grants, totaling $420,000, push the S.L.E. Lupus Foundation's lifetime investment in New York City-based lupus research past $17 millionan unparalleled sum for private sector lupus research funding and investigator training in any single metropolitan area.

"The S.L.E. Lupus Foundation has been key in making New York City the nation's leader in lupus research and results that matter for people with this disease," said Bruce Cronstein, MD, of New York University, chairman of the S.L.E. Lupus Foundation's Medical Advisory Board.

Since 1977, the S.L.E. Lupus Foundation has distributed nearly 200 grants to more than 139 young scientists in the New York area to help ensure that the most talented and ambitious minds enterand remainin the field of lupus research, while building the city as a global center of discovery and care.

With their award funds, the three new grantees will work with mentors to explore potential treatments, and possible causes, for lupus:

  • Dr. Isgro at HSS, a Brooklyn native, will explore with her mentor Alessandra Pernis, MD, PhD, a target for a new lupus therapy that uses statins, which are commonly known drugs for lowering cholesterol.

  • Dr. Ganguly at Columbia University, under the supervision of Boris Reizis, PhD, will test the hypothesis that a newly identified gene is significant in regulating the cause and development of lupus.

  • Dr. Yan at North Shore-LIJ and her mentor Betty Diamond, MD will dig deeper into recent Feinstein Institute discoveries regarding receptor editing in lupus, and aim to show how critical "affector" mechanisms lead to the production of damaging auto-antibodies in lupus.

"As a fellow, you are desperate to find support to stay in the lab," describes 2003 Career Development Award recipient Guillermina Girardi, PhD at the Hospital for Special Surgery (HSS) in Manhattan. "But with the S.L.E. Lupus Foundation's grant you can take the risks and develop new areas of work. It's been really, really important to me."

"The fellowship grant was the very first research grant I ever received," adds Jane Salmon, MD, co-director of the Mary Kirkland Center for Lupus Research at HHS and a 1981 Basic Science Fellowship winner. "It motivated me and made me believe that people had confidence in me as a scientist. It changed my life and it enabled me to begin an independent career, which I've been pursuing now for over 30 years."

And since 2000, as a founding member of the national Lupus Research Institute, the S.L.E. Lupus Foundation has extended its research support to over 100 distinguished scientists across the country pursuing novel approaches to understanding and treating lupusincluding 20 based in New York City.

New York-area academic medical centers with scientists who have received funds from the S.L.E. Lupus Foundation and the Lupus Research Institute include:

  • Hospital for Special Surgery: $4.4 million via 52 grants
  • Albert Einstein College of Medicine: $3.2 million via 39 grants
  • Columbia University Medical Center: $2.6 million via 18 grants
  • NYU/Hospital for Joint Diseases: $2 million via 32 grants
  • North Shore/LIJ-Feinstein Institute: $1.2 million via 16 grants

"Due to our early and ongoing investment, New York City now has the most lupus labs, the most lupus researchers, and the most lupus treatment centers than any other place in the country," said the Foundation's Executive Director Margaret Dowd. "By fostering new scientific talent and building research labs, the Foundation and its New York City partner institutions are leading the way to new treatments and a cure."


'/>"/>

Contact: Liane Stegmaier
lstegmaier@lupusny.org
212-685-4118
Lupus Research Institute
Source:Eurekalert

Related biology news :

1. Gene linked to lupus might explain gender difference in disease risk
2. UT Southwestern researchers probe kidney damage, protection in lupus
3. National report shines light on lupus 50-year treatment drought
4. Genomes of identical twins reveal epigenetic changes that may play role in lupus
5. Lupus Research Institute announces 2009 novel research grants
6. UCLA study identifies genetic variation linked to lupus in Asian men
7. Lupus Research Institute-funded study points to increased risk for lupus in men
8. New clinical test to predict lupus flares moves closer to the market
9. Research uncovers key to understanding cause of lupus
10. New clue to lupus: Failed autoimmune suppression mechanism
11. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology: